On Monday, December 11, from 8:00am-5:00pm, we will perform annual maintenance of our website. During this time, some website functionality will be unavailable. Once complete, anything related to the 2023 session will be moved to the Archives. Mahalo for your understanding!

2024 HOUSE AND SENATE SESSION JOB OPPORTUNITIES AVAILABLE NOW

2012 Archives
You are viewing archived information from 2012

SB2474     
Measure Title: RELATING TO HEALTH.
Report Title: Pseudoephedrine; Prescription Drugs
Description: Reclassifies pseudoephedrine as a schedule V drug that may only be dispensed with a prescription; exempts cold products that contain other active ingredients, with certain conditions.
Companion:
Package: None
Current Referral: HTH, CPN
Introducer(s): GREEN, CHUN OAKLAND, Baker, Shimabukuro, Wakai

Sort by Date Status Text
1/20/2012SIntroduced.
1/23/2012SPassed First Reading.
1/23/2012SReferred to HTH, CPN.
2/7/2012SThe committee(s) on HTH has scheduled a public hearing on 02-13-12 1:15PM in conference room 229.
2/13/2012SThe committee(s) on HTH deferred the measure until 02-15-12 4:00PM in conference room 229.
2/15/2012SThe committee on HTH deferred the measure.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SB2474


No committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.




CommRoomDate/TimeNotice
HTH 229 2/13/2012 1:15 PM View
HTH 229 2/15/2012 4:00 PM View